Publication date: Jul 17, 2024
Nigeria, like many other countries, faced challenges in dental care provision during the COVID-19 pandemic, necessitating limited care to emergencies only. However, the impact of restricted access to dental services on oral health remains a concern, particularly with preventive maintenance care. This study aims to identify the factors associated with dental service utilization during the COVID-19 pandemic among patients attending dental clinics in Nigeria, and their sources of information about COVID-19. This cross-sectional study recruited 500 participants who had visited dental clinics before and during the pandemic. Data were collected through telephone interviews and online questionnaires between September and December 2021. Inferential analyses were conducted using ordered logistic regression models to assess the association between the independent (awareness of emergency dental treatments, knowledge of COVID-19 transmission routes in dentistry, awareness of required preparations in dental practice settings, fear of COVID-19 infection in dental settings), and dependent (utilization of dental services during the pandemic) variables after adjusting for confounding variables (age, sex, educational status, COVID-19 vaccinations status and COVID-19 status of live-in residents). The sources of COVID-19 information by dental patients was also identified. Statistical significance was established at 95% confidence level with a p value
Open Access PDF
| Concepts | Keywords |
|---|---|
| December | COVID-19 |
| Dentistry | Dental service utilization |
| Nigeria | Dental setting |
| Pandemic | Emergency dental treatment |
| Vaccinations | Fear |
| Mass media |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 pandemic |
| disease | MESH | emergencies |
| disease | MESH | oral health |
| disease | MESH | infection |
| disease | MESH | educational status |
| disease | VO | document |
| drug | DRUGBANK | Cysteamine |
| disease | VO | mouth |
| disease | VO | protocol |
| drug | DRUGBANK | Trestolone |
| drug | DRUGBANK | Coenzyme M |
| disease | VO | effective |
| drug | DRUGBANK | L-Isoleucine |
| disease | VO | population |
| disease | IDO | history |
| drug | DRUGBANK | Ademetionine |
| drug | DRUGBANK | Etoperidone |
| drug | DRUGBANK | Medical air |
| disease | MESH | virus infection |
| disease | MESH | bleeding |
| disease | VO | vaccination |
| disease | VO | vaccinated |
| disease | IDO | process |
| disease | MESH | dental fear |
| disease | VO | frequency |
| disease | VO | data set |
| disease | VO | vaccine |
| disease | MESH | uncertainty |
| disease | VO | publication |
| disease | VO | organization |
| disease | VO | inactivation |
| disease | IDO | contact tracing |
| disease | MESH | coronavirus infection |
| disease | IDO | site |
| drug | DRUGBANK | Naproxen |
| drug | DRUGBANK | Abacavir |
| disease | IDO | facility |
| drug | DRUGBANK | Glutamic Acid |